Intuitive Surgical stock drops 33% in 2026 amid competition, AI concerns

Intuitive Surgical (NASDAQ: ISRG) has seen its stock price drop by 33% in 2026, despite being a leader in robotic surgical systems with a market value that recently exceeded $135 billion. The decline is attributed to concerns over increasing competition, particularly from Chinese companies and the potential impact of artificial intelligence advancements. This downturn has caused some investors to sell their shares or avoid the stock altogether.

Despite the challenges, some analysts remain optimistic about Intuitive Surgical's future. The Baron Health Care Fund, for example, believes the company has strong growth potential, projecting mid-teens revenue growth for years to come. They highlight that Intuitive Surgical boasts an impressive installed base of over 12,000 robotic surgery systems across more than 70 countries. This existing infrastructure is a significant advantage, as hospitals may not purchase new systems frequently but continue to invest in instruments, accessories, and servicing. This recurring revenue stream accounted for about 75% of the company's total revenue.

Intuitive Surgical is also actively innovating. The company is launching newer and enhanced systems, expanding into areas such as bronchoscopy, and increasing its use in emergency surgeries. These initiatives position Intuitive Surgical as a robust competitor in the medical device industry, especially when compared to emerging rivals. Analysts on Wall Street generally maintain a positive outlook on the stock, with most recommending it as a buy.

Looking ahead, the impact of recent market pressures and regulatory changes, such as the expiration of Affordable Care Act subsidies and upcoming Medicaid work requirements, may still influence investor sentiment. However, for long-term investors willing to accept some risk, the current dip in Intuitive Surgical's stock could represent a valuable buying opportunity. As the company continues to innovate and adapt, it remains a prominent player in the evolving landscape of healthcare technology.